You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fibrocystic Breast Disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fibrocystic Breast Disease Trial in Almaty (Vitex Agnus Castus Extract)

Completed
  • Fibrocystic Breast Disease
  • Vitex Agnus Castus Extract
  • Almaty, Almaty Region, Kazakhstan
    Kazakh Institute of Oncology and Radiology
Jan 29, 2023

Benign Breast Tumor, Breast Carcinoma, Breast Fibrocystic Change Trial in Rochester (procedure, drug, other)

Recruiting
  • Benign Breast Neoplasm
  • +2 more
  • Biospecimen Collection
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

CELBREA® in Symptomatic Women or With Diagnostic Doubt of Breast

Enrolling by invitation
  • Breast Disease
  • +2 more
  • Celbrea
  • Madrid, Spain
    Hospital Universitario La Paz
May 10, 2023

Chronic Liver Disease, Thyroid Disease, Benign Breast Disease Trial in Seongnam

Enrolling by invitation
  • Chronic Liver Disease
  • +4 more
    • Seongnam, Gyeonggi-do, Korea, Republic of
      Seoul National University Bundang Hospital
    Apr 18, 2023

    Scaleup ofAdapted Breast Cancer Early Diagnosis Program in

    Not yet recruiting
    • Breast Cancer
    • +2 more
      • Butaro, Rwanda
        Partners in Health (Inshuti Mu Buzima)
      Aug 1, 2022

      Johns Hopkins Breast Cancer Program Longitudinal Repository

      Recruiting
      • Breast Cancer
      • Benign Breast Disease
      • Sample collection
      • Baltimore, Maryland
        Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      Apr 20, 2022

      Benign Breast Disease Trial in Pisa (REGENERA)

      Completed
      • Benign Breast Disease
      • REGENERA
      • Pisa, Italy
        Azienda Ospedaliero Universitaria Pisana
      Feb 7, 2022

      Breast Cancer in Rwanda: Scaleup in National Health Care System

      Completed
      • Breast Cancer
      • Benign Breast Disease
      • Early diagnosis program combined with electronic medical record
      • Kigali, Rwanda
        Rwanda Biomedical Centre
      Mar 29, 2022

      Benign Breast Disease Trial in Boston (Vitamin D and fish oil , Fish oil and vitamin D , Vitamin D and fish oil )

      Active, not recruiting
      • Benign Breast Disease
      • Vitamin D and fish oil placebo
      • +3 more
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Apr 6, 2022

      Mastalgia Trial in Cairo (Omega 3 fatty acid, VitaE)

      Not yet recruiting
      • Mastalgia
      • Cairo, Muslim, Egypt
        Rehab Sabry
      Dec 31, 2020

      UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic

      Recruiting
      • Hepato/Renal Fibrocystic Disease
      • +9 more
        • Washington, District of Columbia
          Children's National Health System
        Feb 19, 2021

        Duct Ectasia Breast, Benign Breast Disease Trial in Alexandria (major duct excision)

        Completed
        • Duct Ectasia Breast
        • Benign Breast Disease
        • major duct excision
        • Alexandria, Egypt
          Faculty of Medicine, Main Univeristy Hospital
        Feb 4, 2021

        Risk Factors for Benign Breast Disease

        Recruiting
        • Benign Breast Disease
          • Mansoura, Egypt
            Mansoura University Cancer center
          Nov 18, 2020

          MAstectomy With Reconstruction Including Robot Endoscopic

          Recruiting
          • Breast Neoplasms
          • +4 more
          • Robotic or endoscopic nipple sparing mastectomy
          • Conventional mastectomy (including nipple sparing mastectomy, skin sparing mastectomy)
          • Seoul, Korea, Republic of
            Yonsei University College of Medicine
          Jun 4, 2021

          Genetics of Mammographic Appearances and Patterns

          Completed
          • Benign Breast Disease
            • Burlington, Vermont
              Vermont Cancer Center - Univ of Vermont
            Mar 11, 2020

            Pattern of Clinical Presentation of Different Breast Disease in

            Completed
            • Breast Disease
            • +3 more
              • Dharan, Province 1, Nepal
                BPKIHS
              Sep 4, 2023

              Chronic Pain Trial in Assiut (PRF, SHAM)

              Unknown status
              • Chronic Pain
              • PRF
              • SHAM
              • Assiut, Egypt
                Diab
              Jul 3, 2019

              China CellSearch Study

              Completed
              • Metastatic Breast Cancer
              • Benign Breast Disease
                • Beijing, China
                  307 Hosptial of PLA
                Nov 13, 2019

                HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy Trial (SHR-A1811,

                Not yet recruiting
                • HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy
                • (no location specified)
                Nov 7, 2023

                Residual Disease in Breast Cancer Remission After Primary

                Recruiting
                • Breast Cancer
                • minimally invasive preoperative image-guided vacuum-assisted biopsy
                • Milan, Italy
                  Fondazione IRCCS Istituto Nazionale dei Tumori
                Jul 10, 2023

                Advanced Breast Cancer, Objective Response Rate, Trastuzumab Emtansine Trial in Nanjing (Trastuzumab Emtansine (T-DM1))

                Recruiting
                • Advanced Breast Cancer
                • +2 more
                • Trastuzumab Emtansine (T-DM1)
                • Nanjing, Jiangsu, China
                  JiangSu Province Hospital/ The First Affiliated Hospital of Nanj
                Nov 5, 2023

                Triple Negative Breast Tumors Trial (Pembrolizumab injection, Capecitabine tablets, Local radiotherapy)

                Not yet recruiting
                • Triple Negative Breast Neoplasms
                • Pembrolizumab injection
                • +2 more
                • (no location specified)
                Jul 25, 2023

                DESTINY Breast Respond HER2-low Europe

                Not yet recruiting
                • Unresectable Breast Cancer
                • +2 more
                • Trastuzumab deruxtecan
                • (no location specified)
                Jul 6, 2023

                Breast Cancer Trial in Gainesville (12-week Intervention Period, 12-week Observation Period)

                Not yet recruiting
                • Breast Cancer
                • 12-week Intervention Period
                • 12-week Observation Period
                • Gainesville, Florida
                  Integrative Cardiovascular Physiology Laboratory, University of
                Jun 13, 2023

                Breast Cancer Stage IV, Breast Cancer Metastatic, Communication Trial in San Pedro Garza Garcia (Communication model)

                Not yet recruiting
                • Breast Cancer Stage IV
                • +2 more
                • Communication model
                • San Pedro Garza Garcia, Nuevo Leon, Mexico
                  Hospital Zambrano Hellion
                Apr 28, 2023